Global Female Contraceptive Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146489
- Pages: 250
-
Format:
Report Overview
Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Prudent Markets latest report provides a deep insight into the global Female Contraceptive market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Female Contraceptive Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Female Contraceptive market in any manner.
Global Female Contraceptive Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Market Segmentation (by Type)
Female Contraceptive Devices
Female Contraceptive Drugs
Market Segmentation (by Application)
Online Stores
Retail Outlets
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Female Contraceptive Market
Overview of the regional outlook of the Female Contraceptive Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Female Contraceptive Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Female Contraceptive
1.2 Key Market Segments
1.2.1 Female Contraceptive Segment by Type
1.2.2 Female Contraceptive Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Female Contraceptive Market Overview
2.1 Global Market Overview
2.1.1 Global Female Contraceptive Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Female Contraceptive Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Female Contraceptive Market Competitive Landscape
3.1 Global Female Contraceptive Sales by Manufacturers (2018-2023)
3.2 Global Female Contraceptive Revenue Market Share by Manufacturers (2018-2023)
3.3 Female Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Female Contraceptive Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Female Contraceptive Sales Sites, Area Served, Product Type
3.6 Female Contraceptive Market Competitive Situation and Trends
3.6.1 Female Contraceptive Market Concentration Rate
3.6.2 Global 5 and 10 Largest Female Contraceptive Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Female Contraceptive Industry Chain Analysis
4.1 Female Contraceptive Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Female Contraceptive Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Female Contraceptive Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Female Contraceptive Sales Market Share by Type (2018-2023)
6.3 Global Female Contraceptive Market Size Market Share by Type (2018-2023)
6.4 Global Female Contraceptive Price by Type (2018-2023)
7 Female Contraceptive Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Female Contraceptive Market Sales by Application (2018-2023)
7.3 Global Female Contraceptive Market Size (M USD) by Application (2018-2023)
7.4 Global Female Contraceptive Sales Growth Rate by Application (2018-2023)
8 Female Contraceptive Market Segmentation by Region
8.1 Global Female Contraceptive Sales by Region
8.1.1 Global Female Contraceptive Sales by Region
8.1.2 Global Female Contraceptive Sales Market Share by Region
8.2 North America
8.2.1 North America Female Contraceptive Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Female Contraceptive Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Female Contraceptive Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Female Contraceptive Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Female Contraceptive Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Female Contraceptive Basic Information
9.1.2 Merck Female Contraceptive Product Overview
9.1.3 Merck Female Contraceptive Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Female Contraceptive SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Pfizer
9.2.1 Pfizer Female Contraceptive Basic Information
9.2.2 Pfizer Female Contraceptive Product Overview
9.2.3 Pfizer Female Contraceptive Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Female Contraceptive SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Allergan
9.3.1 Allergan Female Contraceptive Basic Information
9.3.2 Allergan Female Contraceptive Product Overview
9.3.3 Allergan Female Contraceptive Product Market Performance
9.3.4 Allergan Business Overview
9.3.5 Allergan Female Contraceptive SWOT Analysis
9.3.6 Allergan Recent Developments
9.4 Bayer
9.4.1 Bayer Female Contraceptive Basic Information
9.4.2 Bayer Female Contraceptive Product Overview
9.4.3 Bayer Female Contraceptive Product Market Performance
9.4.4 Bayer Business Overview
9.4.5 Bayer Female Contraceptive SWOT Analysis
9.4.6 Bayer Recent Developments
9.5 Okamoto Industries
9.5.1 Okamoto Industries Female Contraceptive Basic Information
9.5.2 Okamoto Industries Female Contraceptive Product Overview
9.5.3 Okamoto Industries Female Contraceptive Product Market Performance
9.5.4 Okamoto Industries Business Overview
9.5.5 Okamoto Industries Female Contraceptive SWOT Analysis
9.5.6 Okamoto Industries Recent Developments
9.6 Reckitt Benckiser
9.6.1 Reckitt Benckiser Female Contraceptive Basic Information
9.6.2 Reckitt Benckiser Female Contraceptive Product Overview
9.6.3 Reckitt Benckiser Female Contraceptive Product Market Performance
9.6.4 Reckitt Benckiser Business Overview
9.6.5 Reckitt Benckiser Recent Developments
9.7 Lupin Pharmaceuticals
9.7.1 Lupin Pharmaceuticals Female Contraceptive Basic Information
9.7.2 Lupin Pharmaceuticals Female Contraceptive Product Overview
9.7.3 Lupin Pharmaceuticals Female Contraceptive Product Market Performance
9.7.4 Lupin Pharmaceuticals Business Overview
9.7.5 Lupin Pharmaceuticals Recent Developments
9.8 Foundation Consumer Healthcare
9.8.1 Foundation Consumer Healthcare Female Contraceptive Basic Information
9.8.2 Foundation Consumer Healthcare Female Contraceptive Product Overview
9.8.3 Foundation Consumer Healthcare Female Contraceptive Product Market Performance
9.8.4 Foundation Consumer Healthcare Business Overview
9.8.5 Foundation Consumer Healthcare Recent Developments
9.9 Teva Pharmaceuticals
9.9.1 Teva Pharmaceuticals Female Contraceptive Basic Information
9.9.2 Teva Pharmaceuticals Female Contraceptive Product Overview
9.9.3 Teva Pharmaceuticals Female Contraceptive Product Market Performance
9.9.4 Teva Pharmaceuticals Business Overview
9.9.5 Teva Pharmaceuticals Recent Developments
9.10 Ansell
9.10.1 Ansell Female Contraceptive Basic Information
9.10.2 Ansell Female Contraceptive Product Overview
9.10.3 Ansell Female Contraceptive Product Market Performance
9.10.4 Ansell Business Overview
9.10.5 Ansell Recent Developments
9.11 Ferring Pharmaceuticals
9.11.1 Ferring Pharmaceuticals Female Contraceptive Basic Information
9.11.2 Ferring Pharmaceuticals Female Contraceptive Product Overview
9.11.3 Ferring Pharmaceuticals Female Contraceptive Product Market Performance
9.11.4 Ferring Pharmaceuticals Business Overview
9.11.5 Ferring Pharmaceuticals Recent Developments
9.12 Fuji Latex
9.12.1 Fuji Latex Female Contraceptive Basic Information
9.12.2 Fuji Latex Female Contraceptive Product Overview
9.12.3 Fuji Latex Female Contraceptive Product Market Performance
9.12.4 Fuji Latex Business Overview
9.12.5 Fuji Latex Recent Developments
9.13 Janssen Pharmaceuticals
9.13.1 Janssen Pharmaceuticals Female Contraceptive Basic Information
9.13.2 Janssen Pharmaceuticals Female Contraceptive Product Overview
9.13.3 Janssen Pharmaceuticals Female Contraceptive Product Market Performance
9.13.4 Janssen Pharmaceuticals Business Overview
9.13.5 Janssen Pharmaceuticals Recent Developments
10 Female Contraceptive Market Forecast by Region
10.1 Global Female Contraceptive Market Size Forecast
10.2 Global Female Contraceptive Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Female Contraceptive Market Size Forecast by Country
10.2.3 Asia Pacific Female Contraceptive Market Size Forecast by Region
10.2.4 South America Female Contraceptive Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Female Contraceptive by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Female Contraceptive Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Female Contraceptive by Type (2024-2029)
11.1.2 Global Female Contraceptive Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Female Contraceptive by Type (2024-2029)
11.2 Global Female Contraceptive Market Forecast by Application (2024-2029)
11.2.1 Global Female Contraceptive Sales (K MT) Forecast by Application
11.2.2 Global Female Contraceptive Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
